UV Clinical A/S
CVR number: 38401572
Strandvejen 100, 2900 Hellerup
rsj@uvclinical.com
tel: 20203005
www.uvclinical.com
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 576.66 | - 411.40 | 33.46 | 150.95 | 2 235.49 |
| Employee benefit expenses | - 849.52 | - 635.17 | -17.16 | -1 430.96 | -2 704.28 |
| Total depreciation | -58.00 | -58.00 | -58.00 | -4.83 | |
| EBIT | -1 484.18 | -1 104.57 | -41.70 | -1 284.84 | - 468.80 |
| Other financial income | 2 290.20 | 2.03 | |||
| Other financial expenses | -87.16 | - 172.39 | -0.17 | -12.92 | -0.42 |
| Pre-tax profit | -1 571.34 | -1 276.97 | 2 248.33 | -1 297.76 | - 467.18 |
| Income taxes | 137.68 | 127.72 | 1 028.88 | 50.00 | |
| Net earnings | -1 433.66 | -1 149.25 | 2 248.33 | - 268.89 | - 417.18 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 120.83 | 62.83 | 4.83 | 597.01 | 5 558.68 |
| Intangible assets total | 120.83 | 62.83 | 4.83 | 597.01 | 5 558.68 |
| Tangible assets total | |||||
| Holdings in group member companies | 11.69 | ||||
| Investments total | 11.69 | ||||
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 117.89 | ||||
| Current other receivables | 46.54 | 98.85 | 10.62 | 78.66 | 91.49 |
| Current deferred tax assets | 137.68 | 127.72 | 1 028.88 | 1 222.91 | |
| Short term receivables total | 184.22 | 226.57 | 10.62 | 1 107.53 | 1 432.29 |
| Cash and bank deposits | 907.93 | 15.93 | 144.34 | 685.93 | 4 252.63 |
| Cash and cash equivalents | 907.93 | 15.93 | 144.34 | 685.93 | 4 252.63 |
| Balance sheet total (assets) | 1 212.98 | 305.33 | 159.79 | 2 402.17 | 11 243.59 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 418.86 | 418.86 | 418.86 | 474.63 | 660.30 |
| Other reserves | 4 335.77 | ||||
| Retained earnings | 39.58 | -1 394.07 | -2 543.32 | 1 471.30 | 3 584.27 |
| Profit of the financial year | -1 433.66 | -1 149.25 | 2 248.33 | - 268.89 | - 417.18 |
| Shareholders equity total | - 975.21 | -2 124.46 | 123.87 | 1 677.04 | 8 163.16 |
| Provisions | 144.03 | ||||
| Non-current other liabilities | 2 120.12 | 2 290.20 | |||
| Non-current liabilities total | 2 120.12 | 2 290.20 | |||
| Current trade creditors | 18.82 | 66.98 | 7.92 | 279.04 | 1 470.42 |
| Other non-interest bearing current liabilities | 49.25 | 72.61 | 28.00 | 446.09 | 1 465.98 |
| Current liabilities total | 68.07 | 139.59 | 35.92 | 725.13 | 2 936.40 |
| Balance sheet total (liabilities) | 1 212.98 | 305.33 | 159.79 | 2 402.17 | 11 243.59 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.